Nanae Sugasaki

Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations

M. Fukuda, Shuntaro Sato, H. Mukae, 2016, Cancer Chemotherapy and Pharmacology.

Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer

Y. Obase, M. Shimada, M. Fukuda, 2019, Thoracic cancer.

Running Title : Pharmacokinetic parameters of gefitinib as predictors Clinical Trial Registration

M. Fukuda, Shuntaro Sato, H. Mukae, 2018 .

Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use

Y. Obase, K. Omagari, H. Mukae, 2019, The American journal of case reports.